Bearing Point Capital’s Merck MRK Stock Holding History

Bearing Point Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,530	Closed	-$252K	–	167
2024 Q4	$252K	Buy	+2,530	New	+$261K	0.05%	146

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bearing Point Capital's MRK Position: Q1 2025 in Review

Bearing Point Capital sold out of Merck (MRK) in Q1 2025, closing a stake of 2,530 shares — an estimated $252K sold.

Bearing Point Capital first reported a position in MRK in Q4 2024 and held it in 1 quarter. The position peaked at $252K in Q4 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Bearing Point Capital reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Bearing Point Capital sold 2,530 Merck shares in Q1 2025, an estimated $252K.
Bearing Point Capital first reported a position in Merck in Q4 2024 and held it in 1 quarter.
Bearing Point Capital's Merck position peaked at $252K in Q4 2024.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Bearing Point Capital's 13F filing for Q1 2025, filed 7 May 2025.